Plus Therapeutics reported $36K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.





Ordinary Share Capital Change Date
Baxter International USD 683M 0 Dec/2024
Dr.Reddys Laboratories INR 832.52M 144K Sep/2025
Haemonetics USD 46.83M 82K Dec/2025
Starpharma Holdings AUD 240.75M 0 Dec/2024
Sun Pharmaceuticals INR 2.4B 35K Sep/2025
Teva Pharmaceutical Industries USD 1.15B 0 Dec/2025